3-112534296-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_022488.5(ATG3):āc.836A>Cā(p.Glu279Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000211 in 1,599,138 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000093 ( 0 hom., cov: 29)
Exomes š: 0.00022 ( 0 hom. )
Consequence
ATG3
NM_022488.5 missense
NM_022488.5 missense
Scores
4
6
9
Clinical Significance
Conservation
PhyloP100: 7.64
Genes affected
ATG3 (HGNC:20962): (autophagy related 3) This gene encodes a ubiquitin-like-conjugating enzyme and is a component of ubiquitination-like systems involved in autophagy, the process of degradation, turnover and recycling of cytoplasmic constituents in eukaryotic cells. This protein is known to play a role in regulation of autophagy during cell death. A pseudogene of this gene is located on chromosome 20. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.41883862).
BS2
High AC in GnomAd4 at 14 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATG3 | NM_022488.5 | c.836A>C | p.Glu279Ala | missense_variant | 11/12 | ENST00000283290.10 | NP_071933.2 | |
ATG3 | NM_001278712.2 | c.836A>C | p.Glu279Ala | missense_variant | 11/11 | NP_001265641.1 | ||
ATG3 | XM_011513074.1 | c.575A>C | p.Glu192Ala | missense_variant | 11/12 | XP_011511376.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATG3 | ENST00000283290.10 | c.836A>C | p.Glu279Ala | missense_variant | 11/12 | 1 | NM_022488.5 | ENSP00000283290.5 | ||
ATG3 | ENST00000402314.6 | c.836A>C | p.Glu279Ala | missense_variant | 11/11 | 1 | ENSP00000385943.2 | |||
ATG3 | ENST00000494571.1 | n.2472A>C | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000928 AC: 14AN: 150820Hom.: 0 Cov.: 29
GnomAD3 genomes
AF:
AC:
14
AN:
150820
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000664 AC: 16AN: 240960Hom.: 0 AF XY: 0.0000536 AC XY: 7AN XY: 130600
GnomAD3 exomes
AF:
AC:
16
AN:
240960
Hom.:
AF XY:
AC XY:
7
AN XY:
130600
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000223 AC: 323AN: 1448318Hom.: 0 Cov.: 38 AF XY: 0.000186 AC XY: 134AN XY: 720588
GnomAD4 exome
AF:
AC:
323
AN:
1448318
Hom.:
Cov.:
38
AF XY:
AC XY:
134
AN XY:
720588
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000928 AC: 14AN: 150820Hom.: 0 Cov.: 29 AF XY: 0.000123 AC XY: 9AN XY: 73468
GnomAD4 genome
AF:
AC:
14
AN:
150820
Hom.:
Cov.:
29
AF XY:
AC XY:
9
AN XY:
73468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 16, 2023 | The c.836A>C (p.E279A) alteration is located in exon 11 (coding exon 11) of the ATG3 gene. This alteration results from a A to C substitution at nucleotide position 836, causing the glutamic acid (E) at amino acid position 279 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
M;M
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D
REVEL
Benign
Sift
Benign
T;D
Sift4G
Benign
T;T
Polyphen
P;P
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at